Influence of particle solubility on the delivery of inhaled manganese to the rat brain: manganese sulfate and manganese tetroxide pharmacokinetics following repeated (14-day) exposure.
about
Update on a Pharmacokinetic-Centric Alternative Tier II Program for MMT-Part I: Program Implementation and Lessons LearnedState-of-the-science review: does manganese exposure during welding pose a neurological risk?Modifying welding process parameters can reduce the neurotoxic potential of manganese-containing welding fumesSub-chronic inhalation of high concentrations of manganese sulfate induces lower airway pathology in rhesus monkeysCombustion-derived nanoparticles: a review of their toxicology following inhalation exposureManganese neurotoxicity and the role of reactive oxygen speciesThe Effect of Nano-Titanium Dioxide on Limb Bud Development of NMRI Mouse Embryo In VivoVanadium exposure induces olfactory dysfunction in an animal model of metal neurotoxicityUsing exposure windows to explore an elusive biomarker: blood manganeseTranslocation of inhaled ultrafine manganese oxide particles to the central nervous systemRisk assessment of an essential element: manganese.Air pollution toxicology--a brief review of the role of the science in shaping the current understanding of air pollution health risks.Manganese accumulation in the olfactory bulbs and other brain regions of "asymptomatic" welders.Direct effects of manganese compounds on dopamine and its metabolite Dopac: an in vitro study.Use of X-ray absorption spectroscopy to speciate manganese in airborne particulate matter from five counties across the United States.Are Internalized Metals a Long-term Health Hazard for Military Veterans?The speciation of metals in mammals influences their toxicokinetics and toxicodynamics and therefore human health risk assessment.Adequacy and consistency of animal studies to evaluate the neurotoxicity of chronic low-level manganese exposure in humans.Subchronic inhalation of soluble manganese induces expression of hypoxia-associated angiogenic genes in adult mouse lungsRedox Dynamics of Mixed Metal (Mn, Cr, and Fe) Ultrafine Particles.New developments in aerosol dosimetry.The mutagenicity and carcinogenicity of inorganic manganese compounds: a synthesis of the evidence.Manganese in occupational arc welding fumes--aspects on physiochemical properties, with focus on solubility.The bioavailability of manganese in welders in relation to its solubility in welding fumes.Environmental manganese compounds accumulate as Mn(II) within the Golgi apparatus of dopamine cells: relationship between speciation, subcellular distribution, and cytotoxicity.Essentiality, toxicity, and uncertainty in the risk assessment of manganese.Manganese promotes increased formation of hydrogen peroxide by activated human macrophages and neutrophils in vitro.Multi-dose-route, multi-species pharmacokinetic models for manganese and their use in risk assessment.Basal Ganglia accumulation and motor assessment following manganese chloride exposure in the C57BL/6 mouse.Manganese tissue dosimetry in rats and monkeys: accounting for dietary and inhaled Mn with physiologically based pharmacokinetic modeling.Hepatoprotective effect of manganese chloride against CCl4-induced liver injury in rats.Tissue distribution of manganese in iron-sufficient or iron-deficient rats after stainless steel welding-fume exposure.Consequences of manganese administration for striatal dopamine and motor behavior in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed C57BL/6 mice.Olfactory transport: a direct route of delivery of inhaled manganese phosphate to the rat brain.Physiologically based pharmacokinetic modeling of fetal and neonatal manganese exposure in humans: describing manganese homeostasis during development.Pharmacokinetic Modeling of Manganese in the Rat IV: Assessing Factors that Contribute to Brain Accumulation During Inhalation ExposurePharmacokinetic Modeling of Manganese. I. Dose Dependencies of Uptake and EliminationPharmacokinetic Modeling of Manganese. II. Hepatic Processing After Ingestion and InhalationPharmacokinetic Modeling of Manganese. III. Physiological Approaches Accounting for Background and Tracer Kinetics
P2860
Q21285142-6332030A-F31D-4026-9EFF-4B3704475A27Q23910026-B081CD42-7DA8-4939-8AEB-F32D5C7CD1E3Q23916362-B359BFB9-D061-4013-8582-69F552EB3075Q24810697-88D855E8-B796-4D85-954E-2720621F5543Q24815866-2228F2E6-7240-4D69-A446-F26D5FCC9DEDQ26853665-183A8CB1-9BDA-45F0-A31A-E0A960A2106DQ28383557-C0026AA8-AC62-4ED3-BFFC-BF596F35DA6CQ28388187-2A87371D-E687-4CE4-8055-CCDFEF70FE10Q28392026-2F47BA23-7E2B-4744-ABBB-0176C32AAC22Q29615577-F4DB6DEF-64A5-4FCE-A94B-484A7E20FACCQ33524444-6255E36D-1A58-4161-8ED8-C01993E7F5FDQ33767751-CB1041BC-61E5-458C-AFF0-312E723417C5Q34824427-0785B8DB-68DA-48F0-99D6-D8555E6DD0CCQ35792928-DEB2F633-8057-45DB-A91E-6C99B35C81C6Q35958515-F7929D25-F8B1-4C56-AD16-BDE206E324E0Q36260521-EE8593D0-F2BA-439D-A28C-72746B9AB136Q36360790-D4400D5A-03B4-4814-902B-AE6E5C93CE7FQ36761929-D7E00339-5643-42C3-BB9E-6636A7DA7EDDQ36782431-C136F2CA-6806-4705-BFB6-C37A12CA6370Q37070835-D4C0E0D5-47DA-4023-A56A-08ED99FE6B69Q37799604-171C067B-0F08-40FD-96E5-EA48081C14AAQ37946963-87E08CFB-E9C7-4824-B6DC-B79F2BEBB9C2Q38045302-FC9DEEBC-CE2D-4B9D-830E-179D826A464AQ38421895-190BDB2F-2394-4EFF-8946-03D93A7B5714Q39022912-08DCAB90-FBBE-4BE7-9AA0-F0F1874A0408Q39909550-534B6CE3-617A-4A03-BAC2-D8AF2FA63636Q42716321-33EC7D73-433B-49A2-9FD0-C16CD00FDE5FQ43573140-366E42E1-8212-44D6-A192-1F4491330F46Q44916322-4BBA6AA8-0F4A-45AA-8FE9-D887885D0476Q46448734-5F778EEA-135C-48BE-90B5-32093B3654C1Q46703604-044CE1C5-AF6E-486C-B9CF-352C7B690545Q48170546-1F677DB4-9074-444E-8382-BEAC31B38592Q48242758-B05535FF-BD2B-42FB-B9A0-49972FBD5F19Q48460894-70C799DA-0FDA-42FE-BECA-0C47F35BFEE3Q53422974-1CFA5348-2452-4230-AFE3-B4D2F356259CQ57383044-B1C79B62-EE79-49F7-B202-ABC1E255CE9FQ57383131-1147EEDF-2196-45CE-8539-6E114A9A4F66Q57383136-F2252E11-E88B-46F8-8D71-0A715580FBE5Q57383140-64D7E3E5-B05C-434B-8FEC-E5264D86C1FB
P2860
Influence of particle solubility on the delivery of inhaled manganese to the rat brain: manganese sulfate and manganese tetroxide pharmacokinetics following repeated (14-day) exposure.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Influence of particle solubili ...... ng repeated (14-day) exposure.
@en
Influence of particle solubili ...... acokinetics following repeated
@nl
type
label
Influence of particle solubili ...... ng repeated (14-day) exposure.
@en
Influence of particle solubili ...... acokinetics following repeated
@nl
prefLabel
Influence of particle solubili ...... ng repeated (14-day) exposure.
@en
Influence of particle solubili ...... acokinetics following repeated
@nl
P2093
P356
P1476
Influence of particle solubili ...... ng repeated (14-day) exposure.
@en
P2093
C U Parkinson
D C Dorman
M F Struve
M W Marshall
P356
10.1006/TAAP.2000.9088
P577
2001-01-01T00:00:00Z